SCHEMBL2217147

SCHEMBL2217147

Oc1ccc2nc(O)sc2c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.66
GAA P10253 1/20 0.66
L3MBTL1 Q9Y468 1/20 0.66
CA12 O43570 1/20 0.56
CA1 P00915 1/20 0.56
CA2 P00918 1/20 0.56
CA4 P22748 1/20 0.56
CA6 P23280 1/20 0.56
CA5A P35218 1/20 0.56
CA9 Q16790 1/20 0.56
CA14 Q9ULX7 1/20 0.56
CA5B Q9Y2D0 1/20 0.56
APP P05067 8/20 0.54
SULT1A1 P50225 3/20 0.54
DYRK1A Q13627 2/20 0.53
HSD17B1 P14061 5/20 0.51
HSD17B2 P37059 4/20 0.51
AR P10275 1/20 0.50
MAPT P10636 1/20 0.50
DYRK1B Q9Y463 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28090972 0.83 CA2 (0.56) HTTGAAL3MBTL1CA12CA1
SCHEMBL1360479 0.81 HTT (0.63) HTTGAAL3MBTL1CA12CA1
SCHEMBL11119182 0.79 NPC1 (0.56) HTTGAAL3MBTL1APPDYRK1A
SCHEMBL10435968 0.79 RAB9A (0.61) HTTGAAL3MBTL1APPDYRK1A
SCHEMBL12844692 0.79 GFER (0.61) HTTGAAL3MBTL1APPSULT1A1
SCHEMBL11691297 0.79 SMN1; SMN2 (0.61) HTTGAAL3MBTL1CA1CA2
SCHEMBL11067971 0.79 RAB9A (0.53) HTTGAAL3MBTL1APPDYRK1A
SCHEMBL906835 0.79 HTT (0.61) HTTGAAL3MBTL1CA12CA1
SCHEMBL7643832 0.79 HTT (0.61) HTTGAAL3MBTL1CA12CA1
SCHEMBL2676185 0.79 HTT (0.61) HTTGAAL3MBTL1CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3494396-B1 CHEMILUMINESCENT AND FLUORESCENT SUBSTRATE PADS AND USES THEREOF PIERCE BIOTECHNOLOGY INC (US) 2025-06-11 EP claimed
US-10722882-B2 Chemiluminescent and fluorescent substrate pads and uses thereof PIERCE BIOTECHNOLOGY, INC. (US) 2020-07-28 US claimed
EP-3494396-A1 CHEMILUMINESCENT AND FLUORESCENT SUBSTRATE PADS AND USES THEREOF Pierce Biotechnology, Inc. (US) 2019-06-12 EP claimed
US-20180043355-A1 CHEMILUMINESCENT AND FLUORESCENT SUBSTRATE PADS AND USES THEREOF PIERCE BIOTECHNOLOGY, INC. 2018-02-15 US claimed
WO-2018027004-A1 CHEMILUMINESCENT AND FLUORESCENT SUBSTRATE PADS AND USES THEREOF PIERCE BIOTECHNOLOGY, INC. (US) 2018-02-08 WO claimed
WO-2006076034-A2 STABILIZED TWO COMPONENT SYSTEM FOR CHEMILUMIESCENT ASSAY IN IMMUNODIAGNOSTICS BHANU, KALRA (US) 2006-07-20 WO claimed
EP-1254252-A4 NOVEL STABILIZED FORMULATIONS FOR CHEMILUMINESCENT ASSAYS GIRI BRIJ P (US) 2006-06-07 EP claimed
US-20050272108-A1 Stabilized two component system for chemiluminescent assay in immunodiagnostics KALRA BHANU 2005-12-08 US claimed
US-6602679-B2 Substrate of an oxidant, stabilizer and buffer with an extended shelf life is useful with enzyme based probes; detecting DNA fragments in DNA sequencing GIRI BRIJ (US) 2003-08-05 US claimed
US-20010046688-A1 Novel stabilized formulations for chemiluminescent assays GIRI BRIJ PAL (US) 2001-11-29 US claimed
WO-2001055446-A1 NOVEL STABILIZED FORMULATIONS FOR CHEMILUMINESCENT ASSAYS GIRI BRIJ PAL (US) 2001-08-02 WO claimed
EP-3494396-B1 CHEMILUMINESCENT AND FLUORESCENT SUBSTRATE PADS AND USES THEREOF PIERCE BIOTECHNOLOGY INC (US) 2025-06-11 EP disclosed
US-11421223-B2 Processes and host cells for genome, pathway, and biomolecular engineering ENEVOLV, INC. (US) 2022-08-23 US disclosed
US-20200321533-A1 COMPOUNDS FOR ORGANIC LIGHT EMITTING DIODE MATERIALS THE SCRIPPS RESEARCH INSTITUTE 2020-10-08 US disclosed
US-10722882-B2 Chemiluminescent and fluorescent substrate pads and uses thereof PIERCE BIOTECHNOLOGY, INC. (US) 2020-07-28 US disclosed
WO-2006076034-A2 STABILIZED TWO COMPONENT SYSTEM FOR CHEMILUMIESCENT ASSAY IN IMMUNODIAGNOSTICS BHANU, KALRA (US) 2006-07-20 WO disclosed
US-20050272108-A1 Stabilized two component system for chemiluminescent assay in immunodiagnostics KALRA BHANU 2005-12-08 US disclosed
US-6602679-B2 Substrate of an oxidant, stabilizer and buffer with an extended shelf life is useful with enzyme based probes; detecting DNA fragments in DNA sequencing GIRI BRIJ (US) 2003-08-05 US disclosed
US-20010046688-A1 Novel stabilized formulations for chemiluminescent assays GIRI BRIJ PAL (US) 2001-11-29 US disclosed
US-5227454-A HIGH TEMPERATURE RESISTANT, BENZOTHIAZOLE-CONTAINING POLYARYL ETHERS BASF AKTIENGESELLSCHAFT (DE) 1993-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200321533-A1 COMPOUNDS FOR ORGANIC LIGHT EMITTING DIODE MATERIALS ALDH1A2, DDT, CLTB HTT 2655/4885GAA 2009/4885L3MBTL1 51/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.